APUS
Apimeds Pharmaceuticals US Inc.

366
Mkt Cap
$25.91M
Volume
273,889.00
52W High
$4.03
52W Low
$0.951
PE Ratio
-4.78
APUS Fundamentals
Price
$2.06
Prev Close
$1.95
Open
$1.98
50D MA
$1.57
Beta
1.77
Avg. Volume
245,769.89
EPS (Annual)
-$0.1188
P/B
3.17
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Apimeds Pharmaceuticals says I love my Ducks with new ai Futures Lab Program collaboration with the University of Oregons Lundquist College of Business
Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (Apimeds) today announced the expansion of the Apimeds ai Futures Lab program through a new collaboration with the University of Oregons Lundquist...
Business Wire·5mo ago
<
...
1
>

Latest APUS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.